BioPharma Drive: Drug Pricing

MARCH 1, 2024

Reeling from a difficult year financially, the pharma unveiled a new oncology division it says will produce eight billion-dollar medicines by 2030.

Drug Research 119

Drug Research Research Drugs 119

BioPharma Drive: Drug Pricing

SEPTEMBER 7, 2023

The Series B round makes Mariana one of the best funded private companies in a growing group of biotechs working on new radiopharmaceutical therapies.

Drug Research 67

Drug Research Research Therapies Drugs 67

BioPharma Drive: Drug Pricing

OCTOBER 22, 2024

A medicine the pharma acquired in a $430 million buyout of Visterra in 2018 succeeded in a Phase 3 trial in IgA nephropathy, a crowded corner of drug research.

Disease 64

Disease Drugs Drug Research Trials 64

BioPharma Drive: Drug Pricing

AUGUST 16, 2024

Some industry watchers described the level of price discounts announced by Medicare as a "relief," though they warned of bigger future implications for drug research.

Drugs 70

Drugs Drug Research Research 70

Drugs.com

OCTOBER 24, 2023

23, 2023 -- New research suggests a link between middle school students being disciplined for marijuana use and legalization of recreational weed, particularly when schools are close to dispensaries that sell the drug. Researchers. MONDAY, Oct.

Drugs 110

Drugs Drug Research Research 110

BioPharma Drive: Drug Pricing

JULY 11, 2023

RA Capital led a Series B financing round that drew participation from more than a dozen blue-chip venture backers, including new investors Goldman Sachs and Vertex Ventures.

Drug Research 43

Drug Research Research Drugs 43

BioPharma Drive: Drug Pricing

JUNE 14, 2023

The alliance is Astellas’ second recent partnership involving protein degraders, an emerging area of drug research the company has made a focus in recent years.

Drugs 67

Drugs Drug Research Research 67

Drug Channels

MARCH 5, 2024

Fein, president of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for DCI’s latest live video webinar: Drug Channel Implications of the Inflation Reduction Act This event will be broadcast live on Friday, April 5, 2024, from 12:00 p.m. to 1:30 p.m. All rights reserved.

Pharmacy 84

Pharmacy Biosimilars Drugs Marketing 84

BioPharma Drive: Drug Pricing

JANUARY 12, 2024

Arena BioWorks, which will be led by Harvard University scientist Stuart Schreiber, seeks to blend academic and venture capital drug research models.

Drug Research 128

Drug Research Research Drugs 128

BioPharma Drive: Drug Pricing

DECEMBER 7, 2023

The funding is indicative of investor interest in an area of drug research that involves at least a dozen startups and multiple publicly traded companies.

Drug Research 131

Drug Research Research Drugs 131

DrugBank

MAY 15, 2024

The road to developing effective drugs is fraught with both promise and challenge, particularly when it comes to what scientists call "undruggable" targets. The Evolution of Drug Discovery: From Dark Rooms to Precision Targets In the past, drug discovery often felt like a lucky guess.

Small Molecule 82

Small Molecule Molecular Biology Drugs Disease 82

Drug Target Review

SEPTEMBER 21, 2023

The research showed that exposing O. The findings supported the possibility put forward by Cotton et al (2016) concerning the chance of repurposing these drugs for adulticidal treatment. Need for adulticidal drugs More than 99 percent of countries worldwide has been affected by this disease. volvulus.

Drugs 105

Drugs Treatment Disease Research 105

Chemical Biology and Drug Design

JULY 5, 2024

Abstract Intestinal absorption of compounds is significant in drug research and development. Then, the molecular dynamics simulation and molecular docking were utilized to study the mechanism of differences in intestinal absorption of drugs and investigate the role of molecular structure.

Drug Research 100

Drug Research Research Drugs 100

BioPharma Drive: Drug Pricing

DECEMBER 13, 2023

The company is now expecting to save $4 billion by the end of 2024, with a majority of the spending cuts coming from drug research and development.

Drug Research 114

Drug Research Research Drugs 114

BioPharma Drive: Drug Pricing

JULY 26, 2023

The startup, which initially aims to make cancer medicines, claims to have a new twist on covalent drug research.

Drugs 52

Drugs Drug Research Research 52

BioPharma Drive: Drug Pricing

AUGUST 15, 2023

More than a dozen startups have joined a few publicly traded biotechs and larger pharmaceutical firms in what’s become one of the most competitive areas in drug research.

Drug Research 98

Drug Research Pharmaceuticals Research Drugs 98

BioPharma Drive: Drug Pricing

JULY 5, 2023

The deal enables Sarepta to quickly cash in on the clearance of Elevidys, with $102 million in new funds to help bankroll its drug research.

Therapies 106

Therapies FDA Drug Research Research 106

Cytel

JUNE 19, 2024

Historically, many drugs have been prescribed to children even though this patient population have largely been excluded from clinical trials.

Clinical Trials 59

Clinical Trials Regulations Drug Research Pharmaceuticals 59

BioPharma Drive: Drug Pricing

MARCH 12, 2024

Allogene’s partnership with Arbor is designed to help the company stand out in what’s quickly become one of the industry’s hottest areas of drug research.

Therapies 70

Therapies Disease Drug Research Research 70

BioPharma Drive: Drug Pricing

FEBRUARY 28, 2024

Well-known scientist and biotech entrepreneur Robert Langer is helping Lindus Health address longstanding challenges in contract drug research.

Drug Research 60

Drug Research Research Drugs 60

Crown Bioscience

AUGUST 2, 2021

Continue reading to learn more about IMIDs and some of the challenges facing the field, and to review some in vivo preclinical models that can be used to guide IMID drug research and development.

Disease 52

Disease Drug Development Immune Response Drugs 52

DrugBank

AUGUST 20, 2024

The world of drug discovery is in a state of transformation, with advancements in biotechnology opening doors to new possibilities for targeting previously "undruggable" disease mechanisms. The Power of Drug Repurposing Explore the immense potential of drug repurposing as a strategy for targeting undruggable targets.

Therapies 72

Therapies Pharmaceuticals Disease Research 72

Vial

MAY 20, 2024

Clinical CROs in Clinical Research Randomized clinical trials are the gold-standard of evidence-based medicine, representing the culmination of the long, arduous drug development pipeline. The two broadest categories of drug development can be separated into the preclinical and clinical research stages. over this period.

Clinical Research 52

Clinical Research Clinical Trials Research Trials 52

BioPharma Drive: Drug Pricing

JULY 6, 2023

The contract services provider, which secured the deal through a reportedly competitive process, expects CorEvitas to expand its drug research business.

Drug Research 52

Drug Research Research Drugs 52

DrugBank

OCTOBER 30, 2024

This lets you focus on what matters most: driving meaningful results in drug research and development. Your Need for Accessible, High-Quality Data—Solved Pharmaceutical research and healthcare innovation demand timely access to comprehensive, up-to-date data.

Production 75

Production Clinical Trials Packaging Compliance 75

DrugBank

SEPTEMBER 12, 2024

At DrugBank we’re committed to improving your daily research and drug development operations. Data Exploration If you’re venturing into a new area of drug research, the Data Dictionary helps you identify relevant data fields and understand their context.

Production 78

Production Government Packaging Research 78

Conversations in Drug Development Trends

FEBRUARY 21, 2024

Also known as a human radiolabeled mass balanced study, the AME study aims to determine the overall metabolism and excretion pathways of the NCE, as well as to identify and quantify circulating metabolites relative to parent or total drug-related exposure.

Clinical Trials 80

Clinical Trials Pharmacy Clinical Pharmacology FDA 80

ACTO

SEPTEMBER 11, 2024

“The life sciences industry is actively looking for new ways to leverage AI to bring drugs to market faster to patients waiting in need,” said Parth Khanna, CEO of ACTO.

Science 52

Science Pharma Companies Production Marketing 52

Agency IQ

JUNE 9, 2023

What will the orphan drug market exclusivity haircut mean for industry? Here, we’re starting some deeper analysis of aspects of the proposal package with a look at the impact of orphan drug provisions, seeing what impact the new provisions and the surrounding uncertainty might have on innovation. no available treatment.

Marketing 40

Marketing Regulations Biosimilars Drugs 40

Drug Target Review

OCTOBER 26, 2023

Alipogene tiparvovec and voretigene neparvovec-rzyl, two recombinant AAV-based gene therapy products, were approved by the European Medicines Agency (EMA) to treat lipoprotein lipase deficiency in 2012 2 and by the US Food and Drug Administration (FDA) to treat inherited retinal dystrophy in 2017, respectively. Nature 578 , 229-236 (2020).

Engineering 105

Engineering Virus Therapies Immune Response 105

Advarra

AUGUST 16, 2022

Orphan drugs have historically faced a number of barriers, such as limited research and development (R&D) investment due to an expected lack of profitability as well as challenges in clinical trial design and recruitment. Before 1983, only 38 orphan drugs had received U.S. Food and Drug Administration (FDA) approval.

Disease 52

Disease Clinical Trials FDA Approval FDA 52

DrugBank

MARCH 22, 2024

There are many obstacles that you have to overcome on the road to success in early-stage drug discovery and drug repurposing research. As a result, the industry is turning to managed data sources and are having to weigh the costs and benefits of open data sources versus enterprise research tools.

Licensing 74

Licensing Licensing Research Production 74

NIH Director's Blog: Drug Development

FEBRUARY 16, 2021

These include drugs that you may have heard about on the news: remdesivir (an antiviral), dexamethasone (a steroid), and monoclonal antibodies from the companies Eli Lilly and Regeneron. And, yes, such drugs might even cure the common cold!) And ACTIV has indeed moved at unprecedented speed since its launch.

Clinical Trials 52

Clinical Trials Trials Hospitals Vaccine 52

The Pharma Data

APRIL 24, 2021

Novartis is advancing Research & Development of next-generation treatments to combat emerging drug resistance. R&D partnerships to combat drug-resistant malaria in Africa. The European & Developing Countries Clinical Trials Partnership (EDCTP) awarded a grant to the new PAMAfrica research consortium led by MMV.

Clinical Trials 52

Clinical Trials Treatment Trials Disease 52

The Pharma Data

NOVEMBER 10, 2020

Growing into a biopharmaceutical company, Innovent has built an integrated platform covering from drug discovery, CMC, clinical development and commercialization. Dr. Liu shared his over 30 years of R&D experience in drug development both in the global pharmaceutical companies and world renowned scientific research institutions.

Biosimilars 52

Biosimilars Clinical Trials International Clinical Development 52

Agency IQ

JUNE 7, 2024

While pre-pandemic, certain manufacturing facilities were required to comply with RRA records requests, the FDA only gained this authority to require compliance from BIMO facilities under the provisions of the Food and Drug Omnibus Reform Act (FDORA) in 2022. “To

FDA 40

FDA Compliance Regulations Production 40

The Pharma Data

MAY 19, 2023

Yancopoulos Innovator Award , named in honor of the pioneering drug researcher and Regeneron co-founder, President and Chief Scientific Officer, for finding an efficient way to identify certain exoplanets that orbit very closely around their stars. Kaitlyn Wang won first place and received the $75,000 George D.

Engineering 52

Engineering International Science Virus 52